Galectin extends rally as company discloses share sales

After piggybacking on yesterday's ICPT news for a ~60% gain, shares of Galectin Therapeutics (GALT) are up another 22% premarket.

The company says that between October 28 and Thursday, it had tapped its ATM for 2.39M in share sales at an average price of $9.99 each for proceeds of $23,883,137. (8-K)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs